On September 30, 2025, ESSA Pharma Inc. reported a putative class action lawsuit against them regarding claims made by shareholders who purchased stock on August 25, 2025. The company plans to vigorously defend this lawsuit, emphasizing they believe they have valid defenses, but the outcome remains uncertain.